{
    "SPADE_UN_26579": {
        "Sequence Information": {
            "Peptide Name": "Temporin-SHa [G10y]",
            "Sequence": "FLSGIVGMLYKLF",
            "Sequence Length": 13,
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-Gram-",
                "Anticancer",
                "Anti-Mammalian Cell"
            ],
            "Binding Target": "1. Lipid Bilayer",
            "Source": "",
            "Gene": "",
            "PDB ID": "",
            "UniProt Entry": [
                {
                    "uniprotId": "B3KYH4",
                    "uniprotUrl": "http://www.uniprot.org/uniprot/B3KYH4",
                    "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that represents a peptide precursor."
                }
            ],
            "Literature": [
                {
                    "Title": "Synthesis of Second-Generation Analogs of Temporin-SHa Peptide Having Broad-Spectrum Antibacterial and Anticancer Effects",
                    "Pubmed ID": "39200058",
                    "Reference": "Antibiotics (Basel). 2024;13:758",
                    "Author": "Khan AI, Nazir S, Haque MNU, Maharjan R, Khan FA, Olleik H, Courvoisier-Dezord E, Maresca M, Shaheen F",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/39200058"
                }
            ],
            "Mass": 1487.85,
            "PI": 8.59,
            "Net Charge": 1,
            "Hydrophobicity": 1.6,
            "Frequent Amino Acids": "LFG",
            "Absent Amino Acids": "ACDEHNOPQRTUW",
            "Basic Residues": 1,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 8,
            "Polar Residues": 5,
            "Positive Residues": 1,
            "Negative Residues": 0,
            "SPADE ID": "SPADE_UN_26579",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_06989",
                    "Similarity": 1.0,
                    "Sequence": "MTQILLFVHVLISFLSLLLIVTNSVEIPETPCESDAECPYYSPSLYARCIDGFCTLFLS"
                },
                {
                    "SPADE_ID": "SPADE_UN_26578",
                    "Similarity": 1.0,
                    "Sequence": "FLSGIVGMLKLF"
                },
                {
                    "SPADE_ID": "SPADE_UN_26579",
                    "Similarity": 1.0,
                    "Sequence": "FLSGIVGMLYKLF"
                }
            ],
            "Hemolytic Activity": "Human bronchial epithelial cells BEAS-2B:IC50=32.0±1.9 µM,Human Lung Fibroblasts IMR-90:IC50=38.2±1.5 µM",
            "Target Organism": "Acinetobacter baumannii DSM 30007(MIC=12.5µM),Enterobacter cloacae DSM 30054(MIC=>100µM),Escherichia coli ATCC 8739(MIC=>100µM),Helicobacter pylori ATCC 43504(MIC=6.25µM),Klebsiella pneumoniae DSM 26371(MIC=>100µM),Pseudomonas aeruginosa ATCC 9027(MIC=>100µM),Bacillus subtilis ATCC 6633(MIC=6.25µM),Enterococcus faecalis DSM 2570(MIC=12.5µM),Enterococcus faecium DSM 20477(MIC=12.5µM),Staphylococcus aureus ATCC 6538(MIC=6.25µM),Human breast adenocarcinoma MCF-7(IC50=13.1±3.6µM),Human hepatocellular carcinoma HepG2(IC50=40.3±7.2µM),Human ovarian adenocarcinoma A2780(IC50=23.2±3.1µM),Human pancreatic carcinoma Mia PaCa-2(IC50=23.9±3.9µM),Human prostate adenocarcinoma PC-3(IC50=19.3±1.2µM),Human skin melanoma MNT-1(IC50=44.1±8.1µM),Human lung carcinoma A549(IC50=22.0±2.1µM)"
        }
    }
}